2012
DOI: 10.4103/2230-8210.93741
|View full text |Cite
|
Sign up to set email alerts
|

Medical management of renal stone

Abstract: Kidney stone is a common clinical problem faced by clinicians. The prevalence of the disease is increasing worldwide. As the affected population is getting younger and recurrence rates are high, dietary modifications, lifestyle changes, and medical management are essential. Patients with recurrent stone disease need careful evaluation for underlying metabolic disorder. Medical management should be used judiciously in all patients with kidney stones, with appropriate individualization. This chapter focuses on m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(11 citation statements)
references
References 32 publications
0
11
0
Order By: Relevance
“…Citrate is an important inhibitor for calcium and oxalate nucleation. Increase in the citrate levels in urine in all the treatment groups indicated the anti urolithiatic activity of the drug [ 18 ]. Increase in their values suggest urolithiatic activities whereas decrease suggest antiurolithiatic function.…”
Section: Discussionmentioning
confidence: 99%
“…Citrate is an important inhibitor for calcium and oxalate nucleation. Increase in the citrate levels in urine in all the treatment groups indicated the anti urolithiatic activity of the drug [ 18 ]. Increase in their values suggest urolithiatic activities whereas decrease suggest antiurolithiatic function.…”
Section: Discussionmentioning
confidence: 99%
“…It could significantly improve ECG and the relief of AP symptoms. The combination therapy of XFZYT and TAMs could also reduce the nitroglycerin use, improve blood HDL-C level which benefits patients with cardiovascular diseases [ 33 ], and decrease blood LDL-C, TG, and TC level which seemed as risk factors of cardiovascular disease [ 34 ]. No significant differences were identified on the incidence of adverse effects between XFZYT plus TAMs and TAMs.…”
Section: Discussionmentioning
confidence: 99%
“…Though this method is used more commonly in the US and some European countries as a first line of treatment for bigger stones, it involves more cost to the patient and is not without risk of damaging kidney or contributing to other form of renal injury, depending on the condition of the patient. 3 (International Journal of Current Advanced Research) Although the above-mentioned treatments are the first line of treatments for bigger stones globally, there is certain class of patients who still do not prefer surgical intervention for the disease for many reasons. These patients then rely on some orthodox medicine or even many superstitions and malpractices are followed to which the normal patient falls prey to.…”
Section: Introductionmentioning
confidence: 99%